Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Antidiabetic activity of S-3483, a site-specific inhibitor of Glc-6-Pase

June 18, 1998

Ebelactone B, a urinary kininase inhibitor, prevents salt-related hypertension in rats

June 18, 1998

Final HOT Study results announced

June 18, 1998

P&U identifies potent distamycin derivatives with improved therapeutic indices

June 18, 1998

Insulin sensitizer induces ovulation in women with PCOS

June 17, 1998

Beta3-adrenoceptor agonist CL-316243 enhances insulin activity in humans

June 17, 1998

New dihydrofolate reductase inhibitors with antitumor and antiparasitic activities

June 17, 1998

DiavaX potential for vaccination against diabetes shown in preclinical models

June 16, 1998

Alexion presents antidiabetic fusion protein at ADA meeting

June 16, 1998

Eprosartan: overview of clinical pharmacology

June 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.